Emcure Pharmaceuticals' IPO worth ₹1,952 crore was subscribed over 67 times on the final day of the bidding (July 5). Qualified institutional buyers subscribed to the IPO 195.83 times, while the non-institutional investor category received over 48 times subscriptions. The retail investor portion saw over seven times subscriptions. The issue had a price band of ₹960 to ₹1,008 per share.